A phase I clinical and pharmacokinetic study of paclitaxel and docetaxel given in combination in patients with solid tumours

European Journal of Cancer

Volumn 42, Issue 12, 2006, Pages 1789-1796

  Izquierdo, Miguel Angel ^a   García, Margarita ^a   Pontón, José Luis ^a   Martínez, Marisa ^a   Valentí, Vicente ^a   Navarro, Matilde ^a   Gil, Miguel ^a   Cardenal, Felipe ^a   Mesía, Ricard ^a   Pérez, Xavier ^a   Salazar, Ramón ^a   Germà Lluch, Josep Ramón ^a  

^a BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

Author keywords

Docetaxel; Paclitaxel; Pharmacokinetics; Phase I; Sequence

Indexed keywords

DOCETAXEL; PACLITAXEL;

ADULT; AGED; ALOPECIA; ANEMIA; AREA UNDER THE CURVE; ARTHRALGIA; ARTICLE; ASTHENIA; BLOOD TOXICITY; BREAST CANCER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG CLEARANCE; DRUG HALF LIFE; DRUG SAFETY; FEBRILE NEUTROPENIA; FEMALE; FLUID RETENTION; HUMAN; HYPERSENSITIVITY REACTION; HYPERTENSION; KIDNEY CANCER; LUNG CANCER; MALE; MYALGIA; NAIL DISEASE; NAUSEA; NEUROPATHY; NEUROTOXICITY; NEUTROPENIA; PERIPHERAL NEUROPATHY; PHASE 1 CLINICAL TRIAL; PHLEBITIS; PRIORITY JOURNAL; SKIN DISEASE; SOLID TUMOR; STOMACH CANCER; STOMATITIS; THROMBOCYTOPENIA; VOMITING;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FEASIBILITY STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PACLITAXEL; TAXOIDS;

EID: 33746804569     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2005.10.031     Document Type: Article

References (25)

1. Von Hoff D.D. The taxoids: same roots, different drugs. Semin Oncol 24 (1997) S13-3-S13-10
2. Bissery M.C., Nohynek G., Sanderink G.J., and Lavelle F. Docetaxel (Taxotere): a review of preclinical and clinical experience. Part I: Preclinical experience. Anticancer Drugs 6 (1995) 339-355 363-8
3. Dorr R.T. Pharmacology of the taxanes. Pharmacotherapy 17 (1997) 96S-104S
4. Fa M.Pa.F. Taxane-mediated gene induction is independent of microtubule stabilization: induction of transcription regulators and enzymes that modulate inflammation and apoptosis. Proc Natl Acad Sci USA 95 (1998) 3896-3901
5. Lin H.L., Liu T.Y., Chau G.Y., Lui W.Y., and Chi C.W. Comparison of 2-methoxyestradiol-induced, docetaxel-induced, and paclitaxel-induced apoptosis in hepatoma cells and its correlation with reactive oxygen species. Cancer 89 (2000) 983-994
6. Vanhoefer U., Cao S., Harstrick A., Seeber S., and Rustum Y.M. Comparative antitumor efficacy of docetaxel and paclitaxel in nude mice bearing human tumor xenografts that overexpress the multidrug resistance protein (MRP). Ann Oncol 8 (1997) 1221-1228
7. Crown J. Docetaxel: overview of an active drug for breast cancer. Oncologist 6 Suppl. 3 (2001) 1-4
8. Valero V., Jones S.E., Von Hoff D.D., Booser D.J., Mennel R.G., Ravdin P.M., et al. A phase II study of docetaxel in patients with paclitaxel-resistant metastatic breast cancer. J Clin Oncol 16 (1998) 3362-3368
9. Kearns C.M. Pharmacokinetics of the taxanes. Pharmacotherapy 17 (1997) 105S-109S
10. van Oosterom A.T., Schrijvers D., and Schriivers D. Docetaxel (Taxotere), a review of preclinical and clinical experience. Part II: Clinical experience. Anticancer Drugs 6 (1995) 356-368
11. Cortes J.E., and Pazdur R. Docetaxel. J Clin Oncol 13 (1995) 2643-2655
12. Eisenhauer E.A., and Vermorken J.B. The taxoids. Comparative clinical pharmacology and therapeutic potential. Drugs 55 (1998) 5-30
13. Piccart M.J., Nogaret J.M., Marcelis L., Longree H., Ries F., Kains J.P., et al. Cisplatin combined with carboplatin: a new way of intensification of platinum dose in the treatment of advanced ovarian cancer. Belgian Study Group for Ovarian Carcinoma. J Natl Cancer Inst 82 (1990) 703-707
14. Stewart D.J., Perrault D.J., Maroun J.A., and Lefebvre B.M. Combined mitoxantrone plus doxorubicin in the treatment of breast cancer. Am J Clin Oncol 10 (1987) 335-340
15. Allen L.M., Tejada F., Okonmah A.D., and Nordqvist S. Combination chemotherapy of the epipodophyllotoxin derivatives, teniposide and etoposide. A pharmacodynamic rationale?. Cancer Chemother Pharmacol 7 (1982) 151-156
16. Baker S.D. Drug interactions with the taxanes. Pharmacotherapy 17 (1997) 126S-132S
17. Lokich J. Phase I clinical trial of weekly combined paclitaxel plus docetaxel in patients with solid tumors. Cancer 89 (2000) 2309-2314
18. Rowinsky E.K., Gilbert M.R., McGuire W.P., Noe D.A., Grochow L.B., Forastiere A.A., et al. Sequences of taxol and cisplatin: a phase I and pharmacologic study. J Clin Oncol 9 (1991) 1692-1703
19. Calvert A.H., Ghokul S., Al-Azraqi A., Wright J., Lind M., Bailey N., et al. Carboplatin and paclitaxel, alone and in combination: dose escalation, measurement of renal function, and role of the p53 tumor suppressor gene. Semin Oncol 26 (1999) 90-94
20. Venturini M., Lunardi G., Del Mastro L., Vannozzi M.O., Tolino G., Numico G., et al. Sequence effect of epirubicin and paclitaxel treatment on pharmacokinetics and toxicity. J Clin Oncol 18 (2000) 2116-2125
21. Itoh K., Sasaki Y., Fujii H., Minami H., Ohtsu T., Wakita H., et al. Study of dose escalation and sequence switching of administration of the combination of docetaxel and doxorubicin in advanced breast cancer. Clin Cancer Res 6 (2000) 4082-4090
22. Cresteil T., Monsarrat B., Dubois J., Sonnier M., Alvinerie P., and Gueritte F. Regioselective metabolism of taxoids by human CYP3A4 and 2C8: structure-activity relationship. Drug Metab Dispos 30 (2002) 438-445
23. Dai D., Zeldin D.C., Blaisdell J.A., Chanas B., Coulter S.J., Ghanayem B.I., et al. Polymorphisms in human CYP2C8 decrease metabolism of the anticancer drug paclitaxel and arachidonic acid. Pharmacogenetics 11 (2001) 597-607
24. Henningsson A., Sparreboom A., Sandstrom M., Freijs A., Larsson R., Bergh J., et al. Population pharmacokinetic modelling of unbound and total plasma concentrations of paclitaxel in cancer patients. Eur J Cancer 39 (2003) 1105-1114
25. Royer I., Monsarrat B., Sonnier M., Wright M., and Cresteil T. Metabolism of docetaxel by human cytochromes P450: interactions with paclitaxel and other antineoplastic drugs. Cancer Res 56 (1996) 58-65